Aortic stiffness is increased in acromegaly - A transthoracic echocardiographic study

International Journal of Cardiology

Volumn 124, Issue 1, 2008, Pages 121-123

  Nemes, Attila ^a   Gavallér, Henriette ^a   Csajbók, Éva ^b   Julesz, János ^b   Forster, Tamás ^a   Csanády, Miklós ^a  

^a Medical Faculty   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acromegaly; Aortic stiffness; Transthoracic echocardiography

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART FUNCTION; HUMAN; HYPOPHYSECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACROMEGALY; ANALYSIS OF VARIANCE; AORTA; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 38349002563     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.196     Document Type: Article

References (19)

1. Melmed S. Acromegaly. N Engl J Med 322 (1990) 966-977
2. Sacca L., Cittadini A., and Fazio S. Growth hormone and the heart. Endocr Rev 15 (1994) 555-573
3. Smith J.C., Lane H., Davies N., et al. The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegaly. J Clin Endocrinol Metab 88 (2003) 2556-2561
4. Eren M., Gorgulu S., Uslu N., et al. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 90 (2004) 37-43
5. Stefanadis C., Stratos C., Boudoulas H., et al. Distensibility of the ascending aorta: comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J 11 (1990) 990-996
6. Corville C., and Mason W.R. The heart in acromegaly. Arch Intern Med 61 (1938) 704-713
7. Clayton R.N. Cardiovascular function in acromegaly. Endocr Rev 24 (2003) 272-277
8. Clayton R.N. New developments in the management of acromegaly. Should we achieve an absolute biochemical cure?. J Endocrinol 155 Suppl 1S (1997) 23-29
9. Orme S.M., McNally R.J.Q., Cartwright R.A., et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 83 (1998) 2730-2734
10. Rajasoorya C., Holdaway I.M., Wrightson P., et al. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41 (1994) 95-102
11. Colao A., Spiezia S., Cerbone G., et al. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol (Oxf) 54 (2001) 515-524
12. Colao A., Marzullo P., and Lombardi G. Effect of six months treatment with Lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly. Eur J Endocrinol 146 (2002) 303-309
13. Brevetti G., Marzullo P., Silvestro A., et al. Early vascular alterations in acromegaly. J Clin Endocrinol Metab 87 (2002) 3174-3179
14. Otsuki M., Kasayama S., Yamamoto H., et al. Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clin Endocrinol (Oxf) 54 (2001) 791-796
15. Thuesen L., Christensen S.E., Weeke J., et al. A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?. Acta Med Scand 223 (1988) 337-343
16. Chanson P., Megnien J.L., del Pino M., et al. Decreased regional blood flow in patients with acromegaly. Clin Endocrinol (Oxf) 49 (1998) 725-731
17. Schiavon F., Maffei P., Martini C., et al. Morphologic study of microcirculation in acromegaly by capillaroscopy. J Clin Endocrinol Metab 84 (1999) 3151-3155
18. Maison P., Demolis P., Young J., et al. Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clin Endocrinol (Oxf) 53 (2000) 445-451
19. Csanady M., Gaspar L., Hogye M., et al. The heart in acromegaly: an echocardiographic study. Int J Cardiol 2 (1983) 349-357